ISSN 1301 - 0883 / E-ISSN 1309 - 3886
 
 







 
 
Search





A rare complication of prolonged bisphosphonate treatment: The osteonecrosis of jaw in a patient with metastatic prostate cancer [Eastern J Med]
Eastern J Med. 2013; 18(4): 217-220

A rare complication of prolonged bisphosphonate treatment: The osteonecrosis of jaw in a patient with metastatic prostate cancer

Mehmet Bilgehan Yuksel1, Bilal Gumus1, Serkan Borazan1, Talha Muezzinoglu1

Bisphosphonates are frequently used for the treatment of bone metastases. We described a 71 years old male with the previous diagnosis of bone metastatic prostate cancer and who underwent hormonotherapy combined with zolendronic acid treatment during 7.5 years and presented the complaints of severe jaw pain and inability of chewing. It was determined that the findings of increased PSA with osteonecrotic area on jaw at radiological imaging. He was urgently diagnosed with the diagnosis of osteonecrosis of jaw related to the long-term zolendronic acid treatment. Bisphosphonate treatment was stopped, and he was treated with conservative treatment, and the disorder was improved by this management. This unclear disorder is required more detailed studies on the terms of ethiology, treatment style, follow-up at the treatment period, and management of complications with the aim of applying these agents more safely.

Keywords: Prostate cancer, bone metastasis, Bisphosphonate treatment, jaw osteonecrosis


Mehmet Bilgehan Yuksel, Bilal Gumus, Serkan Borazan, Talha Muezzinoglu. A rare complication of prolonged bisphosphonate treatment: The osteonecrosis of jaw in a patient with metastatic prostate cancer. Eastern J Med. 2013; 18(4): 217-220


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar




 
Copyright 2019 Eastern Journal of Medicine. All Rights Reserved.
Home        |        Contact
LookUs & OnlineMakale